Xeticam IV 500mg:5mL Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of Xeticam IV 500mg:5mL.

Available Products of Xeticam IV 500mg:5mL

Xeticam IV 500mg:5mL 1's

Reg#: 092964

Description of Xeticam IV 500mg:5mL

Each 5mL contains:Levetiracetam…..500mg

Medicine Info

Pack Size: 1's

Company: Getz Pharma (Pvt.) Limited (000284)

Price of Xeticam IV 500mg:5mL

Price: Rs. 551.80

Related Keywords

  • Xeticam IV 500mg:5mL price in Pakistan
  • Xeticam IV 500mg:5mL tablet price
  • Xeticam IV 500mg:5mL Capsule price
  • Getz Pharma (Pvt.) Limited (000284) Xeticam IV 500mg:5mL price
  • Buy Xeticam IV 500mg:5mL online
  • Xeticam IV 500mg:5mL containslevetiracetam500mg uses
  • Xeticam IV 500mg:5mL syrup price
  • Xeticam IV 500mg:5mL pack 1's cost

Xeticam IV 500mg:5mL 10's

Reg#: 092964

Description of Xeticam IV 500mg:5mL

Each 5mL contains:Levetiracetam…..500mg

Medicine Info

Pack Size: 10's

Company: Getz Pharma (Pvt.) Limited (000284)

Price of Xeticam IV 500mg:5mL

Price: Rs. 5517.98

Related Keywords

  • Xeticam IV 500mg:5mL price in Pakistan
  • Xeticam IV 500mg:5mL tablet price
  • Xeticam IV 500mg:5mL Capsule price
  • Getz Pharma (Pvt.) Limited (000284) Xeticam IV 500mg:5mL price
  • Buy Xeticam IV 500mg:5mL online
  • Xeticam IV 500mg:5mL containslevetiracetam500mg uses
  • Xeticam IV 500mg:5mL syrup price
  • Xeticam IV 500mg:5mL pack 10's cost

Alternatives brands of Xeticam IV 500mg:5mL

Explore alternative brands for Xeticam IV 500mg:5mL below.

View Alternatives

Explore More Medicines

Xeticam Oral Solution 100mg:ml

Getz Pharma (Pvt.) Limited (000284)

MRP: Rs. 702.6833

Xeticam Oral Solution 100mg:ml

Getz Pharma (Pvt.) Limited (000284)

MRP: Rs. 1405.3523

Xeticam Tablets 1000mg

Getz Pharma (Pvt.) Limited (000284)

MRP: Rs. 1513.4117

Xeticam Tablets 1000mg

Getz Pharma (Pvt.) Limited (000284)

MRP: Rs. 4540.2351

Xeticam Tablets 250mg

Getz Pharma (Pvt.) Limited (000284)

MRP: Rs. 531.4401

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!